Knowledge |
To what approximate extent do males contribute to reported cases of infertility globally? |
a. Less than 10% b. 10% - 30% c. 31% - 50% d. 50% or more |
a or b = Gap c or d = No gap |
For each item listed below, please rate your current level of knowledge based on what is expected of your professional role in the care of patients seeking fertility care. Note: If item is NOT relevant to your current professional role, please select Not relevant ("NR"). |
NA |
NA |
/Eligibility for in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) |
1=No knowledge at all; 2=Basic knowledge; 3=Intermediate knowledge; 4=Advanced knowledge; 5=Expert knowledge NR=Not relevant |
1-3 = Gap 4-5 = No gap NR = Excluded from analysis |
/Microsurgical reconstruction of the male genital tract (e.g., vasovasostomy and vasoepididymostomy) |
/Transurethral resection of ejaculatory ducts |
/Techniques for varicocele repair |
/Empirical medical treatment with selective estrogen receptor modulators, antioxidants, and gonadotropin in males |
/Gonadotropin therapy for hormonal disorders in males |
/Treatments for male patients that can improve in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcomes |
/The effectiveness of vaccines available in preventing SARS-CoV-2 infections and limiting symptom severity |
Knowledge |
Please rate your level of agreement with each of the following statements. Note: If you are unsure and/or not informed enough to form an opinion, please select "Unsure". |
NA |
NA |
/Poor embryonic development in an IVF cycle is an indication for ICSI. |
1=Strongly disagree; 2=Disagree; 3=Unsure - not informed enough to form an opinion; 4=Agree; 5=Strongly agree |
3-5 = Gap 1-2 = No gap |
/With the exception of 0% values (globozoospermia) even very low rates of sperm morphology have poor predictive power. |
3-5 = Gap 1-2 = No gap |
Skill |
For each item listed below, please rate your current level of skill according to what is expected of your professional role in the care of patients seeking fertility care. Note: If item is NOT relevant to your current professional role, please select Not relevant ("NR"). |
1=No skill at all; 2=Basic skill level; 3=Intermediate skill level; 4=Advanced skill level; 5=Expert skill level NR=Not relevant |
1-3 = Gap 4-5 = No gap NR = Excluded from analysis |
/Investigating hypothalamic-pituitary axis dysfunction in males |
/Investigating spermatogenic defects |
/Investigating ductal obstruction or dysfunction in males |
/Investigating infectious disease causes of infertility in males |
/Investigating systemic causes of infertility in males |
/Counselling patients on the safety and efficacy of available vaccines (including ones for SARS-CoV-2) |
/Discussing with patients’ evidence regarding the risks versus benefits of SARS-CoV-2 vaccines on pregnancy and birth outcomes |
/Building rapport with patients via telehealth during an initial evaluation |
Skill (decision-making) |
A 45-year-old man and a 32-year-old woman present because they experienced an unsuccessful IVF cycle in another clinic 4 months prior. The previous IVF attempt resulted in 20 mature oocytes and poor embryo development. |
NA |
NA |
/Which assessments would be obtained to guide further treatment? Check all that apply. |
a. Anti-Müllerian hormone b. Anti-sperm antibody titer c. Semen analysis/sperm function test d. Serum testosterone for male e. Serum FSH for male and female f. Genetic tests |
a, b, d, e or f = Incorrect c = Correct |
/All results are normal except semen analysis/sperm function test - 3% of sperm with normal morphology. What is the next best course of action? |
a. A second cycle of conventional IVF b. Split-cycle IVF/ICSI c. ICSI d. Full andrological evaluation by a specialist |
a-c = Incorrect d= Correct |
Attitude |
Please rate your level of agreement with each of the following statements. Note: If you are unsure and/or not informed enough to form an opinion, please select "Unsure". |
NA |
NA |
/Investigating the causes of male infertility is simpler than for female infertility. |
1=Strongly disagree; 2=Disagree; 3=Unsure - not informed enough to form an opinion; 4=Agree; 5=Strongly agree |
4-5 = Gap 1-3 = No gap |
Performance |
How often do you consider the health of a female patients’ male partner when investigating and treating their fertility issues? |
a. Always b. Most of the time c. Sometimes d. Rarely e. Never |
b-e = Gap a = No gap |
System |
Has the COVID-19 pandemic resulted in the following changes? If so, what is the likelihood of each change persisting after the COVID-19 pandemic is over? |
NA |
NA |
/staffing shortages |
Part 1. a. Yes b. No Part 2. 1=Very unlikely 2= Unlikely 3= Unsure 4 = Likely 5 = Very likely |
Part 1. a = Change b = No change Part 2. 4=5 = Likely or very likely 3 = Unsure 1-2 = Unlikely to very unlikely |
/removal of diagnostic tests for fertility (e.g., fallopian tube examination) |
/limited access to labs that perform specialised diagnostic testing (e.g., Anti-Müllerian hormone, genetic testing) |
/limited access to medications needed for fertility treatment |
/policy changes that required a greater prioritisation of patients for fertility treatment than before |
/a more conservative approach to preventing ovarian hyperstimulation syndrome and minimise hospitalisation risk |
/the need to counsel patients on vaccines (including SARS-CoV-2) |
/an uptake in the use of tools and technologies facilitating communication with patients at a distance |